Nampt and Its Potential Role in Inflammation and Type 2 Diabetes
Nampt and Its Potential Role in Inflammation and Type 2 Diabetes
复制标题
DOI:
10.1007/978-3-642-17214-4_7
复制
发表时间:
2011-01-01
期刊:
影响因子:
--
通讯作者:
Kiess, Wieland
中科院分区:
文献类型:
--
作者:
Garten, Antje;Petzold, Stefanie;Kiess, Wieland
Nicotinamide phosphoribosyltransferase (Nampt) is a key nicotinamide adenine dinucleotide (NAD) biosynthetic enzyme in mammals, converting nicotinamide into nicotinamide mononucleotide (NMN), an NAD intermediate. First identified in humans as a cytokine pre-B-cell colony enhancing factor (PBEF) and subsequently described as an insulin-mimetic hormone visfatin, Nampt has recently excited the scientific interest of researchers from diverse fields, including NAD biology, metabolic regulation, and inflammation. As an NAD biosynthetic enzyme, Nampt regulates the activity of NAD-consuming enzymes such as sirtuins and influences a variety of metabolic and stress responses. Nampt plays an important role in the regulation of insulin secretion in pancreatic beta-cells. Nampt also functions as an immunomodulatory cytokine and is involved in the regulation of inflammatory responses. This chapter summarizes the various functional aspects of Nampt and discusses its potential roles in diseases, with special focus on type 2 diabetes mellitus (T2DM).